BackAurinia Pharmaceuticals Overview
Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Target Price

Where could AUPH trade next? Consensus target price: $16.

Get informed when a big investor buys or sells

+ Follow

Share Price

$15.45

Average Target Price

$16.003.6% upside

1 analysts in the last 4 months

High: $16 | Low: $16

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-07RBC CapitalDouglas Miehm$163.6% upsideOpen
2025-12-03Leerink Partners$163.6% upsideOpen
2025-11-04RBC Capital$152.9% downsideOpen
2024-09-06H.C. WainwrightEd Arce$1315.9% downsideOpen
2024-05-02JefferiesMaury Raycroft$661.2% downsideOpen
2023-01-04RBC Capital$1128.8% downsideOpen
2022-08-09H.C. Wainwright$2668.3% upsideOpen
2022-08-08Oppenheimer$1315.9% downsideOpen
2022-05-05H.C. Wainwright$3094.2% upsideOpen
2022-04-28RBC Capital$2242.4% upsideOpen

Aurinia Pharmaceuticals (AUPH) FAQ

The latest target price for AUPH is $16. Investors often review this figure alongside Aurinia Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Aurinia Pharmaceuticals trades near $15.45 while the consensus target sits at $16 (3.6% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting AUPH's target price ($16), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Aurinia Pharmaceuticals's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.